{
    "clinical_study": {
        "@rank": "105987", 
        "arm_group": [
            {
                "arm_group_label": "Air", 
                "arm_group_type": "Experimental", 
                "description": "The participant will undergo epiretinal membrane peeling with fluid-air exchange. The remaining of the surgery is the same in all arms."
            }, 
            {
                "arm_group_label": "Sulfur hexafluoride (SF6)", 
                "arm_group_type": "Active Comparator", 
                "description": "The participant will undergo epiretinal membrane peeling with fluid-SF6 exchange. The remaining of the surgery will stay the same."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if one of these gaz (air and sulfur hexafluoride)\n      is better than the other in epiretinal membrane peeling surgery. Both are already used for\n      this surgery and this study will tell us if one is better than the other."
        }, 
        "brief_title": "Study of Impact of Air vs SF6 20% on Visual Acuity Improvement After Epiretinal Membrane Stripping", 
        "condition": "Epiretinal Membrane", 
        "condition_browse": {
            "mesh_term": "Epiretinal Membrane"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of epiretinal membrane with corresponding optical coherence\n             tomography\n\n          -  ETDRS visual acuity worse or equal to 20/30\n\n          -  Adult able to give consent\n\n        Exclusion Criteria:\n\n          -  Diagnosis of age-related macular degeneration\n\n          -  Opacity blocking the fundus visualisation\n\n          -  Presence of active intraocular inflammation\n\n          -  Presence of intraocular tumor\n\n          -  Presence of retinal detachment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "438", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02030262", 
            "org_study_id": "C13-10-1231"
        }, 
        "intervention": [
            {
                "arm_group_label": "Air", 
                "description": "The intervention starts with a pars plana vitrectomy and then a epiretinal membrane peeling is performed. During the fluid-gaz exchange, the gaz used will be air. The remaining of the intervention is the same between the two arms.", 
                "intervention_name": "Epiretinal membrane peeling with fluid-air exchange", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Sulfur hexafluoride (SF6)", 
                "description": "The intervention starts with a pars plana vitrectomy and then a epiretinal membrane peeling is performed. During the fluid-gaz exchange, the gaz used will be SF6 (sulfur hexafluoride). The remaining of the intervention is the same between the two arms.", 
                "intervention_name": "Epiretinal membrane peeling with fluid-SF6 exchange", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Qu\u00e9bec", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "G1S 4L8"
                }, 
                "name": "Centre universitaire d'ophtalmologie, H\u00f4pital du Saint-Sacrement, CHU de Qu\u00e9bec"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Impact of Air Versus SF6 20% on Visual Acuity Improvement After Epiretinal Membrane Stripping", 
        "overall_official": {
            "affiliation": "Centre de recherche du CHU de Qu\u00e9bec; Universit\u00e9 Laval", 
            "last_name": "Mathieu Caissie, MD, FRCSC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Visual acuity", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02030262"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Qu\u00e9bec, CHU de Qu\u00e9bec", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}